Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the "Research on Adverse Drug events And Report" (RADAR) project.
Orrell KA, Cices AD, Guido N, Majewski S, Ibler E, Huynh T, Rangel SM, Laumann AE, Martini MC, Rademaker AW, West DP, Nardone B. Orrell KA, et al. J Am Acad Dermatol. 2018 Oct;79(4):762-764. doi: 10.1016/j.jaad.2018.03.031. Epub 2018 Mar 27. J Am Acad Dermatol. 2018. PMID: 29601934 No abstract available.
Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
Kelm RC, Ali Y, Orrell K, Rangel SM, Kruse L, Wagner AM, Gerami P, West DP, Nardone B. Kelm RC, et al. J Am Acad Dermatol. 2021 Mar;84(3):862-864. doi: 10.1016/j.jaad.2020.10.050. Epub 2020 Oct 24. J Am Acad Dermatol. 2021. PMID: 33478777 No abstract available.
Melanoma and chronic exposure to contraceptives containing microdoses of ethinylestradiol in young women: a retrospective study from the Research on Adverse Drug Events and Reports (RADAR) project comprising a large Midwestern U.S. patient population.
Mueller K, Verzi AE, Bhatt K, Orrell K, Hagstorm E, Flood K, Schlosser B, Nardone B, West DP. Mueller K, et al. J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e87-e88. doi: 10.1111/jdv.14534. Epub 2017 Sep 14. J Eur Acad Dermatol Venereol. 2018. PMID: 28833586 No abstract available.
Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR ("Research on Adverse Drug events And Reports") program.
Orrell KA, Murphrey M, Kelm RC, Lee HH, Pease DR, Laumann AE, West DP, Nardone B. Orrell KA, et al. J Am Acad Dermatol. 2018 Oct;79(4):777-778. doi: 10.1016/j.jaad.2018.06.024. Epub 2018 Jun 18. J Am Acad Dermatol. 2018. PMID: 29920313 No abstract available.
Reply to: "Aspirin use and the risk of malignant melanoma".
Orrell KA, Rademaker AW, West DP, Nardone B. Orrell KA, et al. J Am Acad Dermatol. 2019 Jan;80(1):e15. doi: 10.1016/j.jaad.2018.08.016. Epub 2018 Aug 23. J Am Acad Dermatol. 2019. PMID: 30145187 No abstract available.
Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP, Kelm RC, Orrell KA, Patel KR, Singam V, Ali Y, Rastogi S, Yousif R, Rangel SM, West DP, Nardone B. Vakharia PP, et al. Among authors: orrell ka. Int J Dermatol. 2020 Apr;59(4):463-468. doi: 10.1111/ijd.14781. Epub 2020 Jan 23. Int J Dermatol. 2020. PMID: 31971260
14 results